Skip to main content
Erschienen in: Osteoporosis International 2/2018

30.10.2017 | Short Communication

Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur

verfasst von: S. L. Greenspan, K. Vujevich, C. Britton, A. Herradura, G. Gruen, I. Tarkin, P. Siska, B. Hamlin, S. Perera

Erschienen in: Osteoporosis International | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Summary

The Fracture Improvement with Teriparatide (Fix-IT) study randomized 13 women with an atypical femur fracture to immediate vs delayed teriparatide therapy; all were followed for 12 months. Results suggested a trend for superior healing and lesser bone mineral density declines in the immediate vs delayed group with no differences in adverse events.

Purpose

Little clinical data are available on the use of teriparatide for the treatment of bisphosphonate-associated atypical femur fractures (AFF). The goal of the Fix-IT study was to determine if immediate therapy with teriparatide was superior for fracture healing after an AFF compared to a 6-month delay in teriparatide therapy.

Methods

This randomized pilot clinical trial included 13 women with an AFF who were randomized to immediate teriparatide vs a delay of 6 months. All were followed for 12 months on teriparatide. The primary outcomes included individual and composite measures of radiologic bone healing (scored 1 point [no healing] to 4 points [complete healing]) at 6 and 12 months. Secondary outcomes included bone mineral density of the unfractured contralateral hip, spine, 1/3 distal radius, and adverse events.

Results

We found there was a trend for superior healing with the composite score (12.6 vs 11.2 at 6 months and 15.4 vs 13.2 at 12 months), and lesser bone mineral density declines at the 1/3 distal radius (12-month change − 1.9 vs − 6.1%) in the immediate vs the delayed group. There were no differences in adverse events. There was one implant failure in the delayed group.

Conclusions

There is a preliminary signal for greater improvements with immediate teriparatide therapy vs delayed therapy. However, because an AFF is a rare event, and only a small number of patients were included, the results must be interpreted with caution.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Suttorp MJ, Motala A, Ewing B, Roth B, Shanman R et al (2012) AHRQ comparative effectiveness reviews. In: Treatment to prevent fractures in men and women with low bone density or osteoporosis: update of a 2007 Report. edn. Rockville (MD): Agency for Healthcare Research and Quality (US) Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Suttorp MJ, Motala A, Ewing B, Roth B, Shanman R et al (2012) AHRQ comparative effectiveness reviews. In: Treatment to prevent fractures in men and women with low bone density or osteoporosis: update of a 2007 Report. edn. Rockville (MD): Agency for Healthcare Research and Quality (US)
2.
Zurück zum Zitat Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res : Off J Am Soc Bone Miner Res 29(1):1–23CrossRef Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res : Off J Am Soc Bone Miner Res 29(1):1–23CrossRef
3.
Zurück zum Zitat Park-Wyllie LY, Mamdani MM, Juurlink DA, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler PJ, Laupacis A (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305(8):783–789CrossRef Park-Wyllie LY, Mamdani MM, Juurlink DA, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler PJ, Laupacis A (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305(8):783–789CrossRef
4.
Zurück zum Zitat Schilcher J, Michaelsson K, Aspenberg P (2011) Bisphoshonate use and atypical fractures of the femoral shaft. N Engl J Med 364(18):1728–1737CrossRef Schilcher J, Michaelsson K, Aspenberg P (2011) Bisphoshonate use and atypical fractures of the femoral shaft. N Engl J Med 364(18):1728–1737CrossRef
5.
Zurück zum Zitat Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R et al (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res : Off J Am Soc Bone Miner Res 25(11):2267–2294CrossRef Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R et al (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res : Off J Am Soc Bone Miner Res 25(11):2267–2294CrossRef
6.
Zurück zum Zitat Im GI, Lee SH (2015) Effect of teriparatide on healing of atypical femoral fractures: a systemic review. J Bone Metab 22(4):183–189CrossRef Im GI, Lee SH (2015) Effect of teriparatide on healing of atypical femoral fractures: a systemic review. J Bone Metab 22(4):183–189CrossRef
7.
Zurück zum Zitat Chiang CY, Zebaze RM, Ghasem-Zadeh A, Iuliano-Burns S, Hardidge A, Seeman E (2013) Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Bone 52(1):360–365CrossRef Chiang CY, Zebaze RM, Ghasem-Zadeh A, Iuliano-Burns S, Hardidge A, Seeman E (2013) Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Bone 52(1):360–365CrossRef
8.
Zurück zum Zitat Kim JT, Jeong HJ, Lee SJ, Kim HJ, Yoo JJ (2016) Adjuvant teriparatide therapy for surgical treatment of femoral fractures; does it work? Hip Pelvis 28(3):148–156CrossRef Kim JT, Jeong HJ, Lee SJ, Kim HJ, Yoo JJ (2016) Adjuvant teriparatide therapy for surgical treatment of femoral fractures; does it work? Hip Pelvis 28(3):148–156CrossRef
9.
Zurück zum Zitat Mastaglia SR, Aguilar G, Oliveri B (2016) Teriparatide for the rapid resolution of delayed healing of atypical fractures associated with long-term bisphosphonate use. Eur J Rheumatol 3(2):87–90CrossRef Mastaglia SR, Aguilar G, Oliveri B (2016) Teriparatide for the rapid resolution of delayed healing of atypical fractures associated with long-term bisphosphonate use. Eur J Rheumatol 3(2):87–90CrossRef
10.
Zurück zum Zitat Bukata SV, Puzas JE (2010) Orthopedic uses of teriparatide. Curr Osteoporos Rep 8(1):28–33CrossRef Bukata SV, Puzas JE (2010) Orthopedic uses of teriparatide. Curr Osteoporos Rep 8(1):28–33CrossRef
11.
Zurück zum Zitat Miyakoshi N, Aizawa T, Sasaki S, Ando S, Maekawa S, Aonuma H, Tsuchie H, Sasaki H, Kasukawa Y, Shimada Y (2015) Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. J Bone Miner Metab 33(5):553–559CrossRef Miyakoshi N, Aizawa T, Sasaki S, Ando S, Maekawa S, Aonuma H, Tsuchie H, Sasaki H, Kasukawa Y, Shimada Y (2015) Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. J Bone Miner Metab 33(5):553–559CrossRef
12.
Zurück zum Zitat Rigler SK, Studenski S, Wallace D, Recker D, Duncan PW (2002) Co-morbidity adjustment for functional outcomes in communtiy-dwelling older adults. ClinRehabil 16(4):420–428 Rigler SK, Studenski S, Wallace D, Recker D, Duncan PW (2002) Co-morbidity adjustment for functional outcomes in communtiy-dwelling older adults. ClinRehabil 16(4):420–428
13.
Zurück zum Zitat Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483CrossRef Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483CrossRef
14.
Zurück zum Zitat Greenspan A (2011) Orthopedic imaging: a practical approach. Lippincott Williams & Wilkins, Philadelphia Greenspan A (2011) Orthopedic imaging: a practical approach. Lippincott Williams & Wilkins, Philadelphia
15.
Zurück zum Zitat Varney LF, Parker RA, Vincelette A, Greenspan SL (1999) Classification of osteoporosis and osteopenia in postmenopausal women is dependent on site-specific analysis. J Clin Densitom 2:275–283CrossRef Varney LF, Parker RA, Vincelette A, Greenspan SL (1999) Classification of osteoporosis and osteopenia in postmenopausal women is dependent on site-specific analysis. J Clin Densitom 2:275–283CrossRef
16.
Zurück zum Zitat Kim SC, Kim DH, Mogun H, Eddings W, Polinski JM, Franklin JM, Solomon DH (2016) Impact of the U.S. Food and Drug Administration’s safety-related announcements on the use of bisphosphonates after hip fracture. J Bone Miner Res : Off J Am Soc Bone Miner Res 31(8):1536–1540CrossRef Kim SC, Kim DH, Mogun H, Eddings W, Polinski JM, Franklin JM, Solomon DH (2016) Impact of the U.S. Food and Drug Administration’s safety-related announcements on the use of bisphosphonates after hip fracture. J Bone Miner Res : Off J Am Soc Bone Miner Res 31(8):1536–1540CrossRef
17.
Zurück zum Zitat Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res : Off J Am Soc Bone Miner Res 29(9):1929–1937CrossRef Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res : Off J Am Soc Bone Miner Res 29(9):1929–1937CrossRef
18.
Zurück zum Zitat Khosla S, Shane E (2016) A crisis in the treatment of osteoporosis. J Bone Miner Res : Off J Am Soc Bone Miner Res 31(8):1485–1487CrossRef Khosla S, Shane E (2016) A crisis in the treatment of osteoporosis. J Bone Miner Res : Off J Am Soc Bone Miner Res 31(8):1485–1487CrossRef
19.
Zurück zum Zitat Jha S, Wang Z, Laucis N, Bhattacharyya T (2015) Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996–2012: an ecological analysis. J Bone Miner Res : Off J Am Soc Bone Miner Res 30(12):2179–2187CrossRef Jha S, Wang Z, Laucis N, Bhattacharyya T (2015) Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996–2012: an ecological analysis. J Bone Miner Res : Off J Am Soc Bone Miner Res 30(12):2179–2187CrossRef
20.
Zurück zum Zitat Watts NB, Aggers D, McCarthy EF, Savage T, Martinez S, Patterson R, Carrithers E, Miller PD (2017) Responses to treatment with teriparatide in patients with atypical femur fractures previously treated with bisphosphonates. J Bone Miner Res : Off J Am Soc Bone Miner Res 32(5):1027–1033CrossRef Watts NB, Aggers D, McCarthy EF, Savage T, Martinez S, Patterson R, Carrithers E, Miller PD (2017) Responses to treatment with teriparatide in patients with atypical femur fractures previously treated with bisphosphonates. J Bone Miner Res : Off J Am Soc Bone Miner Res 32(5):1027–1033CrossRef
21.
Zurück zum Zitat Ellegaard M, Kringelbach T, Syberg S, Petersen S, Beck Jensen JE, Bruel A, Jorgensen NR, Schwarz P (2013) The effect of PTH(1-34) on fracture healing during different loading conditions. J Bone Miner Res : Off J Am Soc Bone Miner Res 28(10):2145–2155CrossRef Ellegaard M, Kringelbach T, Syberg S, Petersen S, Beck Jensen JE, Bruel A, Jorgensen NR, Schwarz P (2013) The effect of PTH(1-34) on fracture healing during different loading conditions. J Bone Miner Res : Off J Am Soc Bone Miner Res 28(10):2145–2155CrossRef
Metadaten
Titel
Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur
verfasst von
S. L. Greenspan
K. Vujevich
C. Britton
A. Herradura
G. Gruen
I. Tarkin
P. Siska
B. Hamlin
S. Perera
Publikationsdatum
30.10.2017
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 2/2018
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-017-4286-7

Weitere Artikel der Ausgabe 2/2018

Osteoporosis International 2/2018 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.